On Feb 10, 2022 Ucello Therapeutics closed a Series A round and raised $25,000,000 from Chengdu Tianfu International Bio-Town Investment & Development, Cowin Venture, Elikon Venture, Matrix Partners China, Northern Light Venture Capital, featuring lead investors Matrix Partners China.
About the company: Ucello Therapeutics is located at China, Asia.
“”
Company website: http://www.ucello.cn
